The Valley Desk

NCT02262741 · Interventional trial

A Phase I Study to Evaluate the Safety, Tolerability and Efficacy of MEDI4736 (Durvalumab) With Tremelimumab in Head and Neck Cancer

Overall registry status Completed

Phase 1

Conditions Squamous Cell Carcinoma of the Head and Neck

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov